Applied Gene Technologies to Develop TB Diagnostic for AsiaGen | GenomeWeb

Applied Gene Technologies to Develop TB Diagnostic for AsiaGen

Nov 05, 2001

SAN FRANCISCO, Nov. 5 – Applied Gene Technologies has entered a development, manufacturing, and marketing deal with Taiwanese biopharmaceutical company AsiaGen, the companies announced Monday.

Applied Gene Technologies, based in San Diego, will develop tuberculosis diagnostics using its Tessera Array Technology for AsiaGen, which received exclusive rights to manufacture and market the product in Asia.

Applied Gene Technologies will receive an upfront payment for the development work, according to the company. Details of the payment were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Articles

Jul 28, 2016

CellMax Life Aims to Advance CTC-Based Early Cancer Detection; Clinical Studies Ongoing

Premium

Aug 29, 2016

Taiwan's iStat Biomedical Gets CE Mark for HPV-Associated Cancer Products

Dec 18, 2015

BioMérieux, Illumina Launch Whole-Genome Sequencing Service to Investigate Staph Outbreaks

Premium

Jun 22, 2016

Insilico Medicine, Asia Genomics Partner on Longevity Research

Aug 05, 2016

IBM Looks to Develop Applications for Nanoscale Sort-by-Size Microfluidics Chip

Premium

Aug 22, 2016

Singlera Raises $20M in Series A Round

Breaking News

The Scan

This Week in Nucleic Acids Research

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

Round and Round We Go

A BMJ study says that about half of former hematology-oncology regulators now work for industry.

Goodbye and Godspeed

Science should wish PhDs who leave academia well, a Nature editorial says.

New Baby Boy

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.